Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biodesix Inc (BDSX)

Biodesix Inc (BDSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 44,145
  • Shares Outstanding, K 146,563
  • Annual Sales, $ 71,320 K
  • Annual Income, $ -42,930 K
  • EBIT $ -34 M
  • EBITDA $ -26 M
  • 60-Month Beta 1.18
  • Price/Sales 0.45
  • Price/Cash Flow N/A
  • Price/Book 2.91
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.35
  • Most Recent Earnings $-0.08 on 05/13/25
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Services

Options Overview Details

View History
  • Implied Volatility 426.35% ( -452.26%)
  • Historical Volatility 195.99%
  • IV Percentile 67%
  • IV Rank 45.49%
  • IV High 878.62% on 05/15/25
  • IV Low 48.89% on 08/15/24
  • Put/Call Vol Ratio 0.01
  • Today's Volume 141
  • Volume Avg (30-Day) 38
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 1,488
  • Open Int (30-Day) 1,372

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.07
  • Number of Estimates 1
  • High Estimate -0.07
  • Low Estimate -0.07
  • Prior Year -0.08
  • Growth Rate Est. (year over year) +12.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1718 +75.32%
on 05/15/25
0.5999 -49.79%
on 04/25/25
-0.2524 (-45.59%)
since 04/16/25
3-Month
0.1718 +75.32%
on 05/15/25
1.0200 -70.47%
on 02/19/25
-0.6838 (-69.42%)
since 02/14/25
52-Week
0.1718 +75.32%
on 05/15/25
2.0400 -85.24%
on 08/30/24
-1.2588 (-80.69%)
since 05/16/24

Most Recent Stories

More News
Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS

BDSX : 0.3012 (+36.91%)
Denver Post Names Biodesix a Winner of Top Workplaces 2025 Award

BDSX : 0.3012 (+36.91%)
Biodesix Announces First Quarter 2025 Results and Highlights

BDSX : 0.3012 (+36.91%)
Biodesix to Report First Quarter 2025 Financial Results on May 13, 2025

BDSX : 0.3012 (+36.91%)
Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types

BDSX : 0.3012 (+36.91%)
BIO : 248.67 (+2.25%)
Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results

BDSX : 0.3012 (+36.91%)
Biodesix to Present at TD Cowen 45th Annual Health Care Conference

BDSX : 0.3012 (+36.91%)
Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

BDSX : 0.3012 (+36.91%)
Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited)

BDSX : 0.3012 (+36.91%)
Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study

BDSX : 0.3012 (+36.91%)

Business Summary

Biodesix Inc. is a data-driven diagnostic solutions company. It offers blood-based tests across the lung cancer continuum of care. The company also offers include diagnostic research, clinical research, development, and testing services to biopharmaceutical companies, as well as develops and commercializes...

See More

Key Turning Points

3rd Resistance Point 0.4905
2nd Resistance Point 0.4201
1st Resistance Point 0.3607
Last Price 0.3012
1st Support Level 0.2309
2nd Support Level 0.1605
3rd Support Level 0.1011

See More

52-Week High 2.0400
Fibonacci 61.8% 1.3263
Fibonacci 50% 1.1059
Fibonacci 38.2% 0.8855
Last Price 0.3012
52-Week Low 0.1718

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar